End-stage heart failure patients treated with stem cells harvested from their own bone marrow experienced 37 percent fewer cardiac events - including deaths and hospital admissions related to heart failure - than a placebo-controlled group, reports a new study. Results from ixCELL-DCM, the largest cell therapy trial for treating heart failure to date, will be presented at the 2016 American College of Cardiology Scientific Session and published online in The Lancet on April 4.... Read MoreInternal Medicine
Division of Cardiovascular Medicine
For over 50 years the Division of Cardiovascular Medicine at the University of Utah has maintained a dedicated team of cardiologists, nurses and staff to provide high quality cardiovascular care to Utahns and residents throughout the Intermountain West. Our mission to serve our patients and their families is firmly linked to our chartered commitment to cutting-edge care of cardiac disease through discovery, research, and education, especially for the next generation of cardiovascular specialists.
From pioneering work on the implantation of the first artificial heart to discovering the genetic basis for cardiac sudden death and the long QT syndrome, this rich legacy of our clinical and research faculty continues today.
Our cardiovascular fellowship program—offering advanced programs in clinical electrophysiology including ablation of atrial fibrillation, the latest technologies in cardiac imaging, and new treatments for heart and vascular diseases—is nationally recognized.
On Jan. 14-15, the University of Utah School of Medicine will become the worldwide focus of heart recovery medicine when leading scientists and clinicians from across the globe come to Salt Lake City for the Utah Cardiac Recovery Symposium (U-CARS). Now in its fourth year, the one-of-a-kind conference has been described as a “think tank” where hundreds of cardiologists, surgeons, radiologists, anesthesiologists, ER physicians, nurses, pharmacists, research scientists and more converge to push forward the field of heart recovery. ... Read MoreInternal Medicine
The Division of Cardiovascular Medicine is pleased to welcome Dr. Michael Adjei-Poku to the faculty as an Associate Professor.... Read MoreInternal Medicine
The Division of Cardiovascular Medicine is pleased to welcome Dr. Anu Abraham to the faculty as an Assistant Professor.... Read MoreInternal Medicine
The Division of Cardiovascular Medicine is pleased to welcome Dr. Omar Wever-Pinzon to the faculty as an assistant professor.... Read MoreInternal Medicine
A new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E). Six unrelated families with the syndrome come from across the globe – United States, Turkey, France, South America, and two from Canada – yet share mutations that cluster in a small region of phosphodiesterase 3A (PDE3A). Functional studies imply the mutations change resistance of blood vessels, an underappreciated mechanism for regulating blood pressure. The findings, published in Nature Genetics, suggest new directions for investigating causes of hypertension in the general population. ... Read MoreInternal Medicine